Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation.
Groot Kormelink T, Powe DG, Kuijpers SA, Abudukelimu A, Fens MH, Pieters EH, Kassing van der Ven WW, Habashy HO, Ellis IO, Blokhuis BR, Thio M, Hennink WE, Storm G, Redegeld FA, Schiffelers RM.
Groot Kormelink T, et al. Among authors: thio m.
Oncotarget. 2014 May 30;5(10):3159-67. doi: 10.18632/oncotarget.1868.
Oncotarget. 2014.
PMID: 24931643
Free PMC article.